← INTERSTELLAR BLENDS
GOAL · THE PATHWAYS BEHIND IT

Cellular Senescence

5 biological pathways sit behind this goal. Each is named, defined in plain English, and carries the strength of the published human evidence for it.

The pathways

What is behind Cellular Senescence

1Senescence / SASP — The Zombie State

Senescence and its inflammatory sasp — cells that stop dividing yet linger, spilling signals that age the surrounding tissue. Evidence A — Human trial evidence.

2NF-κB — The Immune Alarm

The master inflammatory switch — indispensable to defend against threat, corrosive when it never stands down. Evidence B — Preclinical.

3SIRT1 — The Longevity Switch

A sirtuin enzyme that tunes metabolism, DNA repair and mitochondrial health toward the state linked with longer healthspan. Evidence A — Human trial evidence.

4Mitophagy — The Curator

The quality-control program that finds and clears damaged mitochondria, keeping the cellular power grid clean. Evidence B — Preclinical.

5Sonic Hedgehog — The Builder's Blueprint

Sonic Hedgehog — the signal that told your body where to put things while you were an embryo, and that adult tissue still uses to tell stem cells when to divide.

Evidence on these pathways

NF-κB → CD38 NADase. “Regulation of CD38 expression in HASM cells involves the transcription factor NF-κB, and glucocorticoids inhibit this expression through NF-κB-dependent and -independent mechanisms.” — Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-α and dexamethasone. Respiratory Research, 2008, vol 9, 26. doi:10.1186/1465-9921-9-26

NF-κB → COX-2 Induction. “Moreover, the nuclear factor kappa B (NF-κB) inhibitor BAY11‐7085 or the TLR4 neutralizing antibody markedly blocked PM2.5-induced IL-6 and COX-2 expression.” — PM2.5 exposure upregulates pro-inflammatory protein expression in human microglial cells via oxidant stress and TLR4/NF-κB pathway. Ecotoxicology and Environmental Safety, 2024, vol 277, article 116386. doi:10.1016/j.ecoenv.2024.116386

NF-κB → Kynurenine Pathway. “Treatment of vaccinated DCs with pharmacological NF-κB inhibitors ACHP or DHMEQ significantly inhibited IDO1 biosynthesis, suggesting a role for NF-κB signaling in vaccine up-regulation of dendritic cell IDO1.” — Induction of Indoleamine 2, 3-Dioxygenase in Human Dendritic Cells by a Cholera Toxin B Subunit—Proinsulin Vaccine. PLoS ONE, 2015, volume 10, e0118562. doi:10.1371/journal.pone.0118562

NF-κB → Muscle Recovery. “Activation of NF-κB in skeletal muscle leads to degradation of specific muscle proteins, induces inflammation and fibrosis, and blocks the regeneration of myofibers after injury/atrophy.” — Nuclear factor-kappa B signaling in skeletal muscle atrophy. Journal of Molecular Medicine, 2008, volume 86, issue 10, pages 1113-1126. doi:10.1007/s00109-008-0373-8

Formulas that act on these pathways

1Senolytic

Acts on 5 of these pathways: Senescence / SASP, NF-κB, SIRT1, Mitophagy, Sonic Hedgehog.

2Autophagy Activator

Acts on 4 of these pathways: Senescence / SASP, NF-κB, SIRT1, Mitophagy.

3Victorious

Acts on 3 of these pathways: Senescence / SASP, NF-κB, SIRT1.

4Titanium

Acts on 3 of these pathways: Senescence / SASP, NF-κB, SIRT1.

5SIRT1 Activator

Acts on 3 of these pathways: Senescence / SASP, NF-κB, SIRT1.

6Luteolin

Acts on 3 of these pathways: Senescence / SASP, NF-κB, SIRT1.

What this page does not claim

This page names the pathways involved and the published evidence on each. It does not claim that any formula treats, cures or prevents Cellular Senescence. A pathway opens here only on graded, published evidence, under a standard fixed before the evidence was gathered, and every figure above carries its grade.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

Every pathway named, with the published study behind it.  ·  interstellarblends.com ·  Sign in